Schoenberg Mark
Chief Medical Officer
SaleAlert
- Shares
- 60,677
- Price
- $47.05
- Value
- $2,854,853
SEC EDGAR · Forms 3/4/5Updated through Oct 30, 2026•41 filings
URGN
UroGen Pharma Ltd.
Net sales of $2.9M over the last 3 months
1 seller account for the net balance. There is no cluster of three distinct buyers within 30 days. We found no CEO/CFO purchases over 12 months.
How to read this signal
Only open-market P purchases and S sales count toward the signal. Vesting, options, taxes and gifts remain in the source data but do not trigger alerts. Rule 10b5-1 trades are shown as informational.
3-month balance
−$2,854,853
0 buyers · 1 sellers
12-month purchases
$0.00
0 distinct insiders
12-month sales
$4,154,953
1 distinct insiders
Highlighted alerts
2
4 Rule 10b5-1 trades treated as informational
Buying cluster · 30 days
Fewer than three distinct buyers
CEO/CFO purchases · 12 months
No executive purchases found
Get URGN insider trades by API
The same filtered trades as JSON for your scripts, alerts or AI agent, for 5,500+ US companies — plus sentiment, news, financials and breakout setups. Free · every API · 1,000 requests a month · no card required.
URGN overview: breakout setup, X sentiment and insiders in one page →
Form 4 raw → Raspberry
The value is in what we do not call a signal.
The SEC XML stores every transaction. Raspberry keeps that evidence, reads the footnotes and separates voluntary open-market activity from vesting, option exercises, gifts, tax withholding, stock purchase and dividend reinvestment plans and pre-programmed 10b5-1 trades.
91
Raw transactions
Everything returned by the filing
6
Voluntary view
P/S trades after deterministic checks
85
Administrative noise
Stored, never alerted
4
10b5-1
Shown as informational
SEC ownership XML facts
- Code
- S
- Shares
- 2,202
- Price
- $36.69
- Footnotes
- 3
Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. The reporting person was granted RSUs on October 8, 2024 representing 13,450 ordinary shares. The RSUs will vest in three equal annual installments from October 8, 2025.
Raspberry interpretation
Informational — no alert
Reason: tax_withholding. The filing footnotes identify tax withholding.
Recent transactions
Voluntary purchases and sales; administrative noise stays hidden.
Schoenberg Mark
Chief Medical Officer
Sale 10b5-1
- Shares
- 10,000
- Price
- $40.00
- Value
- $400,000
Schoenberg Mark
Chief Medical Officer
Sale 10b5-1
- Shares
- 10,000
- Price
- $35.01
- Value
- $350,100
Schoenberg Mark
Chief Medical Officer
Sale 10b5-1
- Shares
- 10,000
- Price
- $30.00
- Value
- $300,000
Schoenberg Mark
Chief Medical Officer
Sale 10b5-1
- Shares
- 10,000
- Price
- $25.00
- Value
- $250,000
Schoenberg Mark
Chief Medical Officer
SaleAlert
- Shares
- 10,000
- Price
- $17.69
- Value
- $176,900
| Date | Insider | Transaction | Shares | Price | Value | Reading |
|---|---|---|---|---|---|---|
| Aug 20, 2026 | Schoenberg Mark Chief Medical Officer | Sale | 60,677 | $47.05 | $2,854,853 | |
| Jul 09, 2026 | Schoenberg Mark Chief Medical Officer | Sale | 10,000 | $40.00 | $400,000 | |
| Jun 22, 2026 | Schoenberg Mark Chief Medical Officer | Sale | 10,000 | $35.01 | $350,100 | |
| May 08, 2026 | Schoenberg Mark Chief Medical Officer | Sale | 10,000 | $30.00 | $300,000 | |
| Nov 19, 2025 | Schoenberg Mark Chief Medical Officer | Sale | 10,000 | $25.00 | $250,000 | |
| Aug 11, 2025 | Schoenberg Mark Chief Medical Officer | Sale | 10,000 | $17.69 | $176,900 |
“Alert” means a voluntary, unscheduled transaction according to the filing; it is not an investment recommendation. Official source: SEC EDGAR.